Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Can USD 13.9 Million KOMZIFTI Sales Offset a USD 70.2 Million Loss at Kura Oncology (NASDAQ:KURA)?

Research and development was USD 66.9 million against USD 67.9 million, with ziftomenib costs of USD 37.2 million, and selling, general and administrative expense fell to USD 30.2 million from USD 32.8 million. Loss from operations was USD 74.7 million versus USD 80.0 million. …

Vinay Lochav | 12 November 2026

Why Did Securitize (NYSE:SECZ) Jump 22.38% on the River One Deal and a USD 50 Million Buyback?

Key HighlightsSecuritize (NYSE:SECZ) closed up 22.38% on November 10, 2026 after announcing a deal to acquire River One, a platform that connectsStablecoinCapitalto asset-backed lending.The board approved a share buyback of up to USD 50 million, running through December 31, 2027 and funded from cash.Third-quarterRevenuerose …

Vinay Lochav | 12 November 2026

Why Did Ethan Allen (NYSE:ETD) Sink 16.07% as Farooq Kathwari Left the Company?

Leadership transitions at founder-style companies often bring uncertainty, and Ethan Allen's identity has been bound up with its long-serving chief. Investors had valued the company's conservative management, debt-freeBalance Sheetand regular special dividends, and they now face questions about whether strategy andCapitalreturn policy will change. …

Vinay Lochav | 12 November 2026

How Did Gladstone Land (NASDAQ:LAND) Lift Third-Quarter FFO to USD 0.37 a Share From USD 0.05?

Key HighlightsFFO available to common stockholders was USD 15.9 million, or USD 0.37 per share, in the third quarter ended September 30, 2026, against USD 1.7 million, or USD 0.05 per share, a year earlier.Adjusted FFO reached USD 15.1 million, or USD 0.35 per …

Vinay Lochav | 12 November 2026

Why Did iHeartMedia (NASDAQ:IHRT) Collapse About 65% After Slashing Its EBITDA Outlook?

Key HighlightsiHeartMedia (NASDAQ:IHRT) collapsed about 65% on November 10, 2026, closing near USD 0.62 onVolumeof nearly 39 million shares, many times its usual level.Third-quarterRevenuerose 3.3% to USD 1.03 billion, short of the roughly USD 1.05 billion expected, and adjusted EBITDA fell about 17% to …

Vinay Lochav | 12 November 2026

How Did Lithium Argentina (NYSE:LAR) Hold a 67% Cash Margin as Realized Prices Fell About 10%?

At the corporate level, management said it closed a USD 180 million strategicInvestmentfrom Ganfeng in September through a six-year unsecured convertibleDebenturewith a 4% coupon and a conversion price of USD 12.50 per share. That helped fund the October repurchase of USD 200 million of …

Vinay Lochav | 12 November 2026

Why Did Groupon (NASDAQ:GRPN) Sink 23.05% Alongside Gilat on Weak Outlooks?

Key HighlightsGroupon (NASDAQ:GRPN) closed down 23.05% on November 10, 2026 after third-quarterRevenuegrew only 2% and it guided 2026 revenue to USD 500 million to USD 503 million, flat to up 1%.Gilat Satellite Networks (NASDAQ:GILT) fell 20.45% after third-quarter revenue slipped to USD 116.2 million …

Vinay Lochav | 12 November 2026

How Did Lumexa Imaging (NASDAQ:LMRI) Swing to USD 7.2 Million Profit on Just 5.0% Revenue Growth?

The company, which operates about 190 outpatient imaging centers, said advanced procedures such as MRI and CT, which management said reimburse three to four times more than routine scans, reached a record share of volume. Consolidated advanced procedures grew 7.9% to 200,600, and system-wide …

Vinay Lochav | 12 November 2026

Why Did Recurring Revenue Hit 89% of Sales at LENSAR (NASDAQ:LNSR) as Revenue Slipped 1%?

Key HighlightsTotalRevenuefor the third quarter ended September 30, 2026 was USD 14.1 million, down about 1% from USD 14.3 million a year earlier, as system revenue fell to USD 1.5 million from USD 3.5 million.Recurring revenue rose 17% to USD 12.6 million and made …

Vinay Lochav | 12 November 2026

Why Did Paysign (NASDAQ:PAYS) Fall 18.94% Despite 43% Revenue Growth?

Key HighlightsPaysign (NASDAQ:PAYS) closed down 18.94% on November 10, 2026 after disclosing that a plasma customer will move payment processing for 113 centers to another provider by year-end.Third-quarterRevenuerose 43% to a record USD 30.8 million, led by pharma revenue that more than doubled to …

Vinay Lochav | 12 November 2026
Support

Hi! How can we help you today?

Loading…